ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice.

Sun-Jin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.